The General Hospital Corporation

Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet

Eberhard Karls Universitat Tubingen Medizinische F Akultat

Ana Griciuc

Rudolph Emile Tanzi

David R Elmaleh

Timothy M Shoup

Marius Ueffing

Ghazaleh Sadri-Vakili

Blanca Arango-Gonzalez

Sabrina Paganoni

Rudolph Tanzi

The present disclosure relates to a method of treating one or more inflammation conditions induced by a coronavirus infection in a subject in need thereof, comprising administering a pharmaceutical composition comprising a compound of Formula I or Formula II:

Methods of treatment of coronavirus-induced inflammation conditions

Described herein are methods of treating neuron inflammation conditions, for example, Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effective amount of cromolyn or a cromolyn derivative compound.

Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases

The present invention relates to substances for the prophylaxis and treatment of a neurodegenerative disease which is not based on a protein-folding disorder. It further relates to substances for the stabilization of photoreceptors.

Prophylaxis and treatment of a neurodegenerative disease not based on a protein-folding disorder

The present disclosure provides compositions and methods useful for treating or preventing diseases or disorders where beta amyloid accumulation or aggregation contributes to the pathology or symptomology of the disease, for example Alzheimer's disease.

Methods and agents for treating Alzheimer's disease

Growing community of inventors

Somerville, MA, United States of America

Ana Griciuc